LAUREN HORTON: Open Payments
NPI 1356853345 · CORINTH, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$318 in 17 payments from 10 companies in 2025. Trend: 2023 $703 · 2024 $817 · 2025 $318
Food & beverage: $318
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $118 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| UCB, Inc. | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Amgen Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
Products named: AVYCAZ, XIFAXAN, CREON, Nayzilam, GEMTESA, Veozah, DALVANCE, VOQUEZNA.
Industry payments across MS — which companies pay providers there.
